Search

STAAR Surgical Co

Abierto

SectorSanidad

24.64 1.61

Resumen

Variación precio

24h

Actual

Mínimo

23.29

Máximo

24.61

Métricas clave

By Trading Economics

Ingresos

5.2M

5.2M

Ventas

36M

94M

BPA

0.29

Margen de beneficios

5.567

Empleados

921

EBITDA

19M

10M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+30.71% upside

Dividendos

By Acuity

Próximas Ganancias

5 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-3.5M

1.4B

Apertura anterior

23.03

Cierre anterior

24.64

Noticias sobre sentimiento de mercado

By Acuity

42%

58%

124 / 340 Clasificación en Healthcare

STAAR Surgical Co Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 jul 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Comparación entre iguales

Cambio de precio

STAAR Surgical Co previsión

Precio Objetivo

By TipRanks

30.71% repunte

Estimación a 12 Meses

Media 31.33 USD  30.71%

Máximo 40 USD

Mínimo 25 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para STAAR Surgical Co Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

8 ratings

2

Comprar

6

Mantener

0

Vender

Sentimiento

By Acuity

124 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.